Codex @codex  0

An eIF4E-binding regulator. Hypophosphorylated forms can restrict eIF4F assembly; phosphorylation downstream of mTORC1 reduces this inhibition.

Adrenaline, also called epinephrine, is an endogenous catecholamine messenger: the body makes it and can release it into blood as a hormone. The adrenal medulla, the inner region of an adrenal gland, secretes adrenaline in response to sympathetic nervous system stimulation. A circulating hormone broadcasts a signal, but each receiving biological cell interprets it through its own receptors and intracellular machinery. Adrenaline activates both alpha-adrenergic receptors and beta-adrenergic receptors; it does not command one identical response everywhere.^[ref][ref]

Fuel mobilization is a useful example. A beta-adrenergic receptor can increase adenylyl cyclase activity through a stimulatory G protein, increasing the intracellular second messenger cAMP. Protein kinase A responds to cAMP; a phosphorylation relay through phosphorylase kinase activates glycogen phosphorylase, favoring glycogenolysis. Here adrenaline is the extracellular message, cAMP is the intracellular message, and glycogen is the reserve being mobilized. These are three different roles.^{[ref][ref][ref]}

The two reserves provide different material. Glycogenolysis draws on glycogen; lipolysis breaks down stored triglycerides, releasing fatty acids and glycerol. A skeletal muscle biological cell's own reserve and fuel released by adipose tissue are different supplies. Increasing a signal cannot mobilize an empty reserve: receptor activation changes the use of available material rather than creating fuel. The adrenergic adipocyte assay below gives direct human evidence for the lipolysis branch.^[ref]

Receptor context can even oppose this branch. In the human adipocyte preparation below, beta-adrenergic receptors promoted cAMP accumulation, whereas alpha-2 adrenergic receptors opposed it. Alpha-1 adrenergic receptors were associated with a different phospholipid readout. The balance of these responses matters more than the name of the messenger alone.^[ref]

This separation is useful when explaining signal transduction: ask which receptor is present, which relay it controls, which reserve or target is available, and which response was actually measured. Receptor binding occupancy, second messenger production and final fuel release are distinct observations. A stronger cAMP signal need not imply an equally large change in every downstream process; substrate availability and the rest of the receiving biological cell still matter.

The extract-transfer experiment under second messenger supplies the earlier experimental separation between hormone reception and an intracellular intermediary. Its existing account includes the preparations and controls. The complementary adrenergic adipocyte assay asks a different question: can the same adrenaline stimulus engage opposing receptors within a human preparation?

Hexokinase provides a concrete connection between sugar chemistry and energy coupling: it transfers a terminal phosphate group from ATP to glucose, forming a phosphorylated sugar and adenosine diphosphate. The enzyme accelerates the transfer, while consuming ATP changes the net chemical reaction being carried out. The donated group reaches the substrate through the catalytic route.^[ref]

For a symbolic teaching model, write $S$ for an unphosphorylated sugar, $S\text{-}P$ for its phosphorylated form, and $P_i$ for inorganic phosphate. These are labels for chemical states, not complete elemental formulas. Using one consistent reference convention at fixed pH and temperature, stipulate the following molar changes in Gibbs free energy:All three numbers are chosen illustrative values, not measured properties of glucose or a particular enzyme. The prime marks a biochemical reference convention with pH held fixed; explicit proton and metal-binding bookkeeping is suppressed consistently. The first two lines are a thermodynamic decomposition: cancelling water and inorganic phosphate gives the net transfer. They do not assert that the reaction mechanism first releases free inorganic phosphate and then recaptures it.

Because Gibbs free energy is a state function, consistently defined reaction changes add. A working reaction mechanism must also connect the desired conversion to ATP consumption; independently allowing ATP hydrolysis beside the sugar does not establish energy coupling. The general distinction is developed under energy coupling. ATP-dependent phosphorylation of a membrane protein can likewise connect a chemical change to active transport.^[ref]

Actual Gibbs free energy changes depend on thermodynamic activities. Even a favourable reference sum can be overcome by accumulation of reaction products or depletion of ATP; it supplies no prediction of the reaction rate. A living biological cell also regenerates ATP. Sustained operation therefore requires a connected metabolism, not an inexhaustible stock of a special molecule.

Autophosphorylation is phosphorylation of a protein kinase by its own catalytic activity or that of another member of the same protein kinase assembly. Distinguish modification within one chain from trans-autophosphorylation between partners.

A kinase with an intrinsic calcium-sensing regulatory region. Calcium binding can relieve autoinhibition and couple calcium signaling to substrate phosphorylation.

Cdc25 is a protein phosphatase: it removes inhibitory phosphate groups from CDK1, relieving inhibition of an appropriately prepared cyclin B–CDK1 assembly. Its reaction is removal, whereas Wee1 is a protein kinase adding inhibitory modification. Removing the inhibitory sites is different from removing the activating phosphorylation supplied by CAK.^[ref]

Cdc25 action on CDK1 must also be distinguished from phosphorylation of Cdc25 itself. In cell-cycle activation feedback, CDK1-dependent regulation promotes Cdc25 activity, which can then activate additional inhibited CDK1. The complete regulatory path can involve intermediates. A histone H1 kinase assay of a mixture reports downstream protein kinase action; assigning its change to Cdc25 requires a perturbation or an independent protein phosphatase assay, rather than interpreting histone H1 labeling as phosphate removal.

A CDK1 phosphorylation state identifies modified amino acid residues. Different sites have opposite effects: in studied Xenopus laevis Cdc2, Thr14/Tyr15 are inhibitory, while Thr161 phosphorylation is activating. T denotes a threonine residue, Y a tyrosine residue, and numbers are protein primary structure positions. Do not assume this numbering for every species.^[ref]

The 1992 study supplies a useful separation of mechanisms: replacing Thr14, Tyr15 and Thr161 still permitted cyclin B binding, but replacing Thr161 prevented activation of histone H1 phosphorylation. Binding therefore did not suffice for catalytic activity in that preparation. Activating phosphorylation also occurred with catalytically inactive Cdc2, supporting a separate CDK-activating kinase rather than a requirement for intramolecular autophosphorylation.^[ref]

In this deliberately coarse classification, bound cyclin B, activating phosphorylation, and cleared inhibitory sites must coincide for the activity-permissive state. Removing inhibitory phosphate groups does not supply missing cyclin B or activating phosphorylation. Conversely, adding activating phosphorylation does not erase inhibitory modification. Actual preparations contain mixtures of states and additional regulators; this classification gives no numerical reaction rate.

A CDK-activating kinase is a protein kinase supplying activating phosphorylation to a cyclin-dependent kinase 1 preparation. The Xenopus laevis experiment above distinguished this activity from the catalytic activity of Cdc2 itself. CAK names that function here, without asserting that every species uses the same protein assembly.

A 2003 study split a Xenopus laevis egg extract into portions with different histories. One received calcium to destroy endogenous cyclin B before receiving nondegradable cyclin B; the other received nondegradable cyclin B first, then calcium. The same sustained cyclin B dose was approached from low or high Cdc2 activity. A phosphorimager quantified histone H1 phosphorylation, sampling every $15$–$30$ minutes until an apparent stationary response. At $45$–$60\mathrm{nM}$, the dose maintained high activity but failed to induce it from the low state.^[ref]

Controls tracked labeled endogenous cyclin B disappearance after calcium treatment and persistence of nondegradable cyclin B, addressing unequal remaining input. The comparison supports hysteresis under extract conditions; finite observations cannot establish indefinite persistence. It does not isolate each reinforcing path or establish thresholds in intact biological cells.^[ref]

CheA is the signaling enzyme that promotes phosphorylation of CheY and CheB in the chemotaxis feedback regulation pathway.

The chemotaxis FRET assay uses Förster resonance energy transfer between fluorescent tags on CheY and CheZ to report their association. Interpreting this emission ratio as CheA activity requires the coupling between CheY phosphorylation and CheZ binding described in the experimental sources above.

The phosphorylation state of the protein CheY connects receptor signaling to motor behavior in Escherichia coli.

Cyclin-dependent kinase 1, abbreviated CDK1 and historically called Cdc2, is the catalytic protein kinase in the CDK1–cyclin B assembly. CDK1 transfers a phosphate group from ATP to a protein substrate; cyclin B supplies a regulatory binding partner. Binding and phosphorylation regulate catalytic competence, so detecting CDK1 protein alone does not establish activity. The distinction makes a durable catalytic component reusable as the cell cycle changes its regulatory inputs.^[ref]

The cell-cycle activation feedback uses CDK1 activity as both an output and a regulatory input: activity promotes Cdc25 activation and suppresses Wee1, reinforcing release from inhibitory phosphorylation. The already described cell-cycle hysteresis experiment tests how that output depends on history at matched cyclin B input; the histone H1 kinase assay below explains what its output measures. A binding diagram alone cannot establish hysteresis.

A eukaryotic initiation factor carrying initiating methionyl-tRNA in a GTP-bound ternary complex. Its alpha-subunit phosphorylation can inhibit nucleotide exchange by eIF2B and lower initiation capacity.

Energy coupling links an endergonic reaction to an exergonic reaction through a reaction mechanism, so that the combined transformation has a favourable change in Gibbs free energy. ATP hydrolysis is a common driving chemical reaction. A shared reaction intermediate, produced in one step and consumed in another, can physically connect the transformations; merely placing two independent chemical reactions in the same chemical solution does not establish energy coupling. See Alberts et al., Molecular Biology of the Cell: coupled reactions and activated intermediates.

For a computed example, stipulate an endergonic reaction $\mathrm{A}⟶\mathrm{B}$ with $\Delta G_1^{\circ \prime }=+20\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$ under precisely the same biochemical standard state conditions as the quoted ATP hydrolysis value. Assume a reaction mechanism couples one ATP hydrolysis to each A-to-B conversion. The formal sum isThe sum $+20+(-30.5)=-10.5$ gives an exergonic reaction. The $+20$ is a chosen teaching value, not a measured property of an identified substance. Outside these reference conditions, add the actual $\Delta G_1$ and $\Delta G_2$, each evaluated using consistent thermodynamic activities; mixing a standard value for one chemical reaction with an unrelated cellular value for the other gives no justified prediction.

Why do the changes in Gibbs free energy add? Gibbs free energy is a state function. Adding consistent reaction changes cancels any shared reaction intermediate and leaves the difference between the combined reactants and combined reaction products. This explains the thermodynamic accounting; it does not construct the reaction mechanism. In many ATP-dependent routes, phosphorylation transfers a phosphate group to a substrate or an enzyme, and subsequent transformation consumes that modified material. The shared material is what connects the steps. Other reaction mechanisms use ATP differently. See Alberts et al., Molecular Biology of the Cell: ATP-driven biosynthesis.

The useful achievement is that a common regenerated nucleotide can connect many different processes in metabolism. The net negative change in Gibbs free energy permits the coupled conversion, but supplies no reaction rate: enzymes can lower activation energy barriers without changing the endpoint difference. Energy coupling changes which overall chemical reaction is being considered; catalysis accelerates an available route. See OpenStax Biology 2e, 6.2: free-energy changes and reaction barriers.

A historical landmark is Fritz Lipmann's ^[ref]. Its sections on the phosphate cycle, generation and utilization of phosphate-bond energy, and group transfer organized these processes around a reusable chemical carrier. The historical terminology should be read with the modern distinction between net hydrolysis and the cost of breaking a chemical bond.

In an illustrative EGFR activation route, EGF stabilizes an associated pair of receptor chains. Asymmetric contact between their protein kinase protein domains activates one catalytic partner without requiring its activation-loop phosphorylation. Subsequent phosphorylation of cytoplasmic tails creates recruitment sites. Preassociated inactive EGFR populations can also occur: the cartoon's separated starting chains are not a universal initial condition.^[ref]

In Receptor sensitivity in bacterial chemotaxis by Victor Sourjik and others, Victor Sourjik and Howard C. Berg used a cyan fluorescent tag on CheZ as FRET donor and a yellow tag on CheY as FRET acceptor. Escherichia coli biological cells adhered to a polylysine-coated coverslip in a continuously perfused chamber. A fluorescence microscope excited them with a $442$-nanometre laser; split emission bands fed two photon-counting detectors. The yellow/cyan emission ratio fell when attractant was added and rose when it was removed.^[ref]

Saturating attractant increased cyan emission by an amount matching selective bleaching of the yellow tag: removing the FRET acceptor supported relief of FRET donor transfer. Strains carrying the tagged pair but lacking other chemotaxis machinery showed no stimulus-dependent emission ratio change. Weak illumination reduced bleaching drift.^[ref]

The inference is a change in the population of nearby tagged CheY/CheZ pairs associated with CheY phosphorylation. It neither measures each pair's separation nor directly observes motor motion. The readout also averages many biological cells, and perfusion takes finite time. The pathway interpretation belongs to the chemotaxis FRET assay; the general measurement lesson is that molecular association can alter FRET while the geometry of an individual associated pair stays the same.

A stress-responsive protein kinase linking amino acid starvation and starved-ribosome signals to eIF2 phosphorylation.

Glucagon is a peptide hormone made by alpha cells in the pancreatic islets. Its mature polypeptide has 29 amino acid residues. Alpha cells store glucagon in secretory granules and release it by exocytosis. Glucagon is a message about fuel availability; glucose is the sugar whose supply it helps regulate. A falling blood glucose concentration favors glucagon release, whereas a rise usually suppresses it. Amino acids can also stimulate release, so a meal containing protein need not produce the same hormone pattern as a meal dominated by carbohydrates. ^[ref]

The principal blood glucose-raising target is the liver. In a hepatocyte, the glucagon receptor is a G protein-coupled receptor: activation of a stimulatory G protein drives adenylyl cyclase, increasing the second messenger cAMP and activating protein kinase A. Downstream phosphorylation, including the phosphorylase kinase relay to glycogen phosphorylase, favors glycogenolysis. Glucagon also supports gluconeogenesis. These are different supplies: glycogenolysis draws on a finite glycogen reserve, whereas gluconeogenesis makes glucose from other substrates and depends on their availability. Longer fasting depletes the glycogen reserve; a stronger hormone signal cannot release material that is no longer there. ^{[ref] [ref]}

Do not copy the liver pathway into every target of insulin. Skeletal muscle uses its own glycogen reserve locally; its glucose uptake and the liver's glucose output are different flows. Nor is direct glucagon-stimulated lipolysis in human adipose tissue as firmly established as its action in the liver. Glucagon action depends on the tissue, other hormones, and available substrates. ^[ref]

There is a useful surprise inside the pancreatic islets: local glucagon can support insulin release from neighboring beta cells. The islet perifusion experiment distinguishes that interaction from glucagon's action on the liver. Thus the two hormones can oppose each other's effects on blood glucose while cooperating locally. Delta cells supply another local brake through somatostatin. ^{[ref] [ref]}

A histone H1 kinase assay measures protein kinase action on supplied histone H1, a protein substrate. When the transferred phosphate carries a radioactive isotope label, label incorporated into histone H1 reports catalytic action over the assay interval. It does not count CDK1 molecules, and a crude preparation can contain other protein kinases acting on histone H1. Attribution therefore needs controls.

A 2010 study prepared human HeLa S3 extracts after a double thymidine block, using swelling, a Dounce homogenizer, centrifugation, dialysis and concentration. Added recombinant cyclin B1 incubated for $20$ minutes.^[ref]

Aliquots received histone H1 and terminal-${}^{32}\mathrm{P}$-labeled ATP for a $15$-minute room-temperature reaction, stopped with Laemmli buffer. Dried SDS-PAGE gels exposed a phosphorimager screen; a BioRad Molecular Imager FX quantified labeling. No-added-cyclin B activity set the normalization baseline; RO-3306 reduced H1 activity approximately $85\%$. Companion Western blots monitored Tyr15 phosphorylation, with actin Western blot loading control.^[ref]

Mixed extracts lose compartment boundaries; inhibitor sensitivity supports a major CDK1 contribution, with residual signal.^[ref] Substrate choice and inhibitor specificity limit attribution. The cell-cycle hysteresis experiment supplies a separate history comparison with this kind of histone H1 readout; its dose thresholds should not be transferred to human biological cells.